{"product_id":"comprehensive-review-of-psychiatry-2019","title":"Comprehensive Review of Psychiatry 2019","description":"\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"prod-format\"\u003e\n\u003cbr\u003e\u003cbr\u003eThis Product is shared via google drive download link, So please share your correct Gmail id while placing the order .\u003cbr\u003e\u003cbr\u003ePlease note that there are no CME points or certificate associated with this course\u003cbr\u003e\u003cbr\u003eFormat : 45 Video Files (.mp4 format) + 2 PDF File.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"prod-filesize\"\u003e\n\u003cbr\u003e\u003cbr\u003eFile Size : 8.2 GB\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"prod-format\"\u003e\n\u003cbr\u003e\u003cbr\u003eOakstone Publishing is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.\u003cbr\u003e\u003cbr\u003eOakstone Publishing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eDesignation\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eOakstone Publishing designates this enduring material for a maximum of 40.5 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.\u003cbr\u003e\u003cbr\u003eContact hours: 40.5\u003cbr\u003eThe contact hours are inclusive of 3.75 hours of pharmacotherapeutics.\u003cbr\u003e\u003cbr\u003eDate of Original Release: November 30, 2019\u003cbr\u003eDate Credits Expire: November 30, 2022\u003cbr\u003e\u003cbr\u003eCME credit is awarded upon successful completion of a course evaluation and a post-test.\u003cbr\u003e\u003cbr\u003eThe American Board of Psychiatry and Neurology has reviewed the Comprehensive Review of Psychiatry and has approved this program as part of a comprehensive self-assessment program, which is mandated by the ABMS as a necessary component of Maintenance of Certification.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eUnique Learning Objectives\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eAt the conclusion of this CME activity, you will be better able to:\u003c\/li\u003e\n\u003cli\u003eDescribe interventions and treatments for opioid use disorder\u003c\/li\u003e\n\u003cli\u003eDifferentiate between major depressive disorder and bipolar disorder\u003c\/li\u003e\n\u003cli\u003eSummarize the techniques used in motivational interviewing\u003c\/li\u003e\n\u003cli\u003eOutline medical-psychiatric co-morbid disorders and their clinical management\u003c\/li\u003e\n\u003cli\u003eSummarize the methods used for treatment-resistant depression\u003c\/li\u003e\n\u003cli\u003eDifferentiate among generalized anxiety disorder, panic disorder, and social anxiety disorder\u003c\/li\u003e\n\u003cli\u003eExplain the diagnosis and management of age-related cognitive decline\u003c\/li\u003e\n\u003cli\u003eDiscuss the diagnosis and treatment of ADHD and related disorders\u003c\/li\u003e\n\u003cli\u003eList effective and evidence-based anti-depressants and their efficacy\u003c\/li\u003e\n\u003cli\u003eExplain the characteristics of burnout\u003c\/li\u003e\n\u003cli\u003eIntended Audience\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003eThis activity is intended for psychiatrists or psychiatry residents.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTopics\/Speaker:\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eApproach to the Patient\u003cbr\u003e\u003cbr\u003eFinal Common Brain Pathways of Neuropsychiatric Symptoms – David Silberweig, MD\u003cbr\u003eDisorders\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eSchizophrenia – Oliver Freudenreich, MD, FACLP\u003c\/li\u003e\n\u003cli\u003eDepression – Nassir Ghaemi, MD, MPH\u003c\/li\u003e\n\u003cli\u003eBipolar Illness: Diagnosis – Nassir Ghaemi, MD, MPH\u003c\/li\u003e\n\u003cli\u003eThe Dimensions of Personality – John M. Oldham MD\u003c\/li\u003e\n\u003cli\u003eUpdate on Anxiety Disorders – Mark H. Pollack, MD\u003c\/li\u003e\n\u003cli\u003eObsessive-Compulsive Disorders – Wayne Goodman, MD\u003c\/li\u003e\n\u003cli\u003eImpulse Control and Related Disorders – Emil F. Coccaro, MD\u003c\/li\u003e\n\u003cli\u003eBody Dysmorphic Disorder – Katharine A. Phillips, MD\u003c\/li\u003e\n\u003cli\u003eDiagnosis and Treatment of Age-Related Cognitive Decline – Gary Small, MD\u003c\/li\u003e\n\u003cli\u003eCatatonia – Scott R. Beach, MD\u003c\/li\u003e\n\u003cli\u003eEating Disorders – Harry A. Brandt, MD\u003c\/li\u003e\n\u003cli\u003ePosttraumatic Stress Disorder and Stress-Related Syndromes – Robert J. Ursano MD\u003c\/li\u003e\n\u003cli\u003eMolecular Mimicry, Autoimmunity, and Psychopathology – Sheldon Benjamin, MD\u003c\/li\u003e\n\u003cli\u003eSubstance Use Disorders: Tobacco\/Nicotine – Hasmeena Kathuria, MD\u003c\/li\u003e\n\u003cli\u003eSubstance Use Disorders: Alcohol – Grace Chang, MD, MPH\u003c\/li\u003e\n\u003cli\u003eOpioid Use Disorder and Long-Term Opioid Therapy – Dustin Patil, MD\u003c\/li\u003e\n\u003cli\u003eSubstance Use Disorders: Cannabis – Arthur Robin Williams, MD, MBE\u003c\/li\u003e\n\u003cli\u003eInsomnia – Karl Doghramji, MD\u003c\/li\u003e\n\u003cli\u003ePain and Somatic Symptom Disorder in Psychiatry – Robert M. McCarron, DO\u003c\/li\u003e\n\u003cli\u003eSomatic Symptom Disorders – Joel E. Dimsdale, MD\u003c\/li\u003e\n\u003cli\u003eSuicide – Mark A. Schechter, MD\u003c\/li\u003e\n\u003cli\u003ePost Partum Disorders – Marlene P. Freeman, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eChild and Adolescent Psychiatry\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eIntegrative Approaches to ADHD Management Across the Lifespan: Children, Adolescents, and Adults – Anthony L. Rostain, MD\u003c\/li\u003e\n\u003cli\u003eADHD and Stimulants – Timothy E. Wilens, MD\u003c\/li\u003e\n\u003cli\u003eAnxiety Disorders and Depression in Children and Adolescents – John Sargent, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eTreatments: Psychopharmacologic\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eMoodStabilizers: Second Messenger Modifiers – Nassir Ghaemi, MD, MPH\u003c\/li\u003e\n\u003cli\u003eAntidepressants: Monoamine Agonists – Nassir Ghaemi, MD, MPH\u003c\/li\u003e\n\u003cli\u003eAntipsychotic Drug Treatment of Schizophrenia – Jeffrey A. Lieberman, MD\u003c\/li\u003e\n\u003cli\u003eAnxiolytics – Edward Silberman, MD\u003c\/li\u003e\n\u003cli\u003eSubstance Use Disorder Psychopharmacology, Overview and Updates – Dustin Patil, MD\u003c\/li\u003e\n\u003cli\u003ePractical Aspects of Prescribing Stimulant Medications – Anthony L. Rostain, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eTreatments: Psychotherapy\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eCognitive Behavioral Therapy – Stefan G. Hofmann, PhD\u003c\/li\u003e\n\u003cli\u003eBrief Psychodynamic and Interpersonal Therapy – Mark A. Schechter, MD\u003c\/li\u003e\n\u003cli\u003eMotivational Interviewing – Joji Suzuki, MD\u003c\/li\u003e\n\u003cli\u003eFamily Therapy – John Sargent, MD\u003c\/li\u003e\n\u003cli\u003ePositive Psychiatry – Dilip Jeste, MD\u003c\/li\u003e\n\u003cli\u003eTreatments: Brain Stimulation Therapies\u003c\/li\u003e\n\u003cli\u003eTreating Treatment Resistant Depression – Stephen Seiner, MD\u003c\/li\u003e\n\u003cli\u003eTreatment-Resistant Depression – David L. Dunner MD, FACPsych\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eMedical Psychiatry\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eClinical Challenge of Integrating Medical and Psychiatric Care – Paul Summergrad, MD\u003c\/li\u003e\n\u003cli\u003eIntegrating Medical and Psychiatric Care – Paul Summergrad, MD\u003c\/li\u003e\n\u003cli\u003eEthical and Legal Issues\u003c\/li\u003e\n\u003cli\u003eBurnout – Carol A. Bernstein, MD\u003c\/li\u003e\n\u003cli\u003eInvoluntary Care and Capacity and Guardianship – Rebecca Weintraub Brendel MD, JD\u003c\/li\u003e\n\u003cli\u003eRisk Assessment for Violence – Phillip J. Resnick, MD\u003c\/li\u003e\n\u003cli\u003eEthics \u0026amp; Professionalism – Laura B. Dunn, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e ","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954396729442,"sku":"MED-AMB02629","price":5.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Comprehensive-Review-of-Psychiatry-2019.jpg?v=1779375345","url":"https:\/\/meducourse.com\/products\/comprehensive-review-of-psychiatry-2019","provider":"Meducourse","version":"1.0","type":"link"}